Takara Bio voluntary retirement program draws 148 employees, costs rise to ¥ 1.71 billion

PUBT · 2d ago
Takara Bio voluntary retirement program draws 148 employees, costs rise to ¥ 1.71 billion
  • Takara Bio drew 148 applicants for a voluntary retirement program, above a plan for about 120.
  • Extra retirement costs seen at JPY 1.71 billion in FY2027, booked as an extraordinary loss; JPY 1.65 billion slated for Q1.
  • Annual personnel cost savings projected at JPY 1.11 billion, with JPY 576 million expected in FY2027.
  • Takara Bio signed a basic agreement with Sumitomo Chemical, Sumitomo Pharma, S-RACMO to transfer its GMP cell-processing CDMO business.
  • Definitive agreement targeted around October 2026; Takara Bio to refocus CDMO on nucleic acids/plasmids, proteins/enzymes, viral vectors.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Takara Holdings Inc. published the original content used to generate this news brief on July 21, 2026, and is solely responsible for the information contained therein.